JPMorgan Chase (JPM)
NYSEFinancialsBanks - DiversifiedSnapshot 2026-10-29
$343.58+1.26%
Close 2026-10-29 · 1-day change
NYSEFinancialsBanks - DiversifiedSnapshot 2026-10-29
Research Workspace
Put JPM beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisManagement screens strong on capital allocation.
View ManagementExpectations look high — the market is pricing in about 18% growth a year, above the roughly 8% analysts expect, leaving little room for error.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskJPM’s franchise and revenue growth are the core case, though growth slowed from 27% to 8% year over year. The latest quarter missed adjusted earnings expectations by 3.2%. JPM trades at 2.5× book value versus 1.3× for peers and 2.4× its own history. The market is pricing in more growth than our forecast, leaving expectations full. Fragile cash backing and the latest earnings miss threaten the growth case. Our model puts the next-quarter miss probability near 16%. Peer multiples imply a price about 18% below where it trades; our read remains intact. This read is provisional.
Trailing returns as of 2026-10-29. JPM is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 27 analysts currently covering JPM (as of Oct 2026).
Based on 11 Wall Street analysts offering 12-month price targets for JPM in the last 4 months.
Continue this research
Compare JPM with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| JPM Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Financials (broad) — fair value, gap to price, and forward P/E.
Compare the value case
Put JPM next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Increase net income and revenue growth
Higher net interest income outlook supports revenue growth, though valuation concern is not itself a thesis change.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
Current $343.58
The last 12 months of price, then the range of analyst 12-month targets from today’s $343.58.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
Retail IPO mandate could generate fees and support investment-banking activity.
Anthropic retail IPO role could add advisory and distribution fees.
Threatens: Maintain strong capital and liquidity position
A roughly $6 billion skyscraper raises capital-allocation concerns, though it does not establish funding or returns.
Reported IPO retail mandate may generate fees, though details remain unconfirmed.
Bloomberg-reported IPO sales role could add investment-banking and distribution fees.
Reported retail IPO selection could add fees, though not confirmed by the company.
Allegations involving a former banker present reputational and potential legal risk.
